福氏志贺氏菌
S-亚硝基谷胱甘肽
微生物学
化学
志贺氏菌病
离体
志贺氏菌
生物
体外
谷胱甘肽
生物化学
大肠杆菌
基因
酶
作者
Mathurin Flamant,P. Aubert,Malvyne Rolli‐Derkinderen,Arnaud Bourreille,M. Neunlist,Maxime M. Mahé,G. Meurette,Benoît Marteyn,Tor Savidge,J P Galmiche,Philippe Sansonetti,M. Neunlist
出处
期刊:Gut
[BMJ]
日期:2010-12-07
卷期号:60 (4): 473-484
被引量:90
标识
DOI:10.1136/gut.2010.229237
摘要
Background
Enteric glial cells (EGCs) are important regulators of intestinal epithelial barrier (IEB) functions. EGC-derived S-nitrosoglutathione (GSNO) has been shown to regulate IEB permeability. Whether EGCs and GSNO protect the IEB during infectious insult by pathogens such as Shigella flexneri is not known. Methods
S flexneri effects were characterised using in vitro coculture models of Caco-2 cells and EGCs (or GSNO), ex vivo human colonic mucosa, and in vivo ligated rabbit intestinal loops. The effect of EGCs on S flexneri-induced changes in the invasion area and the inflammatory response were analysed by combining immunohistochemical, ELISA and PCR methods. Expression of small G-proteins was analysed by western blot. Expression of ZO-1 and localisation of bacteria were analysed by fluorescence microscopy. Results
EGCs significantly reduced barrier lesions and inflammatory response induced by S flexneri in Caco-2 monolayers. The EGC-mediated effects were reproduced by GSNO, but not by reduced glutathione, and pharmacological inhibition of pathways involved in GSNO synthesis reduced EGC protecting effects. Furthermore, expression of Cdc42 and phospho-PAK in Caco-2 monolayers was significantly reduced in the presence of EGCs or GSNO. In addition, changes in ZO-1 expression and distribution induced by S flexneri were prevented by EGCs and GSNO. Finally, GSNO reduced S flexneri-induced lesions of the IEB in human mucosal colonic explants and in a rabbit model of shigellosis. Conclusion
These results highlight a major protective function of EGCs and GSNO in the IEB against S flexneri attack. Consequently, this study lays the scientific basis for using GSNO to reduce barrier susceptibility to infectious or inflammatory challenge.
科研通智能强力驱动
Strongly Powered by AbleSci AI